Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) CEO Amir Heshmatpour acquired 3,000 shares of the business's stock in a transaction that occurred on Monday, August 17th. The shares were bought at an average price of $4.37 per share, for a total transaction of $13,110.00. Following the completion of the purchase, the chief executive officer owned 3,087,000 shares of the company's stock, valued at approximately $13,490,190. This represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Neonc Technologies Trading Up 16.4%
Neonc Technologies stock opened at $4.91 on Tuesday. The firm has a 50 day simple moving average of $4.11 and a 200-day simple moving average of $6.05. Neonc Technologies Holdings, Inc. has a 12-month low of $3.01 and a 12-month high of $12.99.
Neonc Technologies (NASDAQ:NTHI - Get Free Report) last released its earnings results on Friday, August 14th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.46).
Analysts Set New Price Targets
Several analysts have issued reports on NTHI shares. Maxim Group assumed coverage on shares of Neonc Technologies in a research note on Monday, May 18th. They set a "buy" rating and a $20.00 target price on the stock. BTIG Research reissued a "buy" rating and set a $15.00 price target on shares of Neonc Technologies in a research report on Tuesday, May 26th. Wall Street Zen downgraded Neonc Technologies from a "hold" rating to a "sell" rating in a research note on Saturday. Weiss Ratings lowered Neonc Technologies from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, June 24th. Finally, Alliance Global Partners initiated coverage on Neonc Technologies in a research note on Tuesday, May 19th. They set a "buy" rating and a $13.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $16.00.
Check Out Our Latest Stock Analysis on Neonc Technologies
Hedge Funds Weigh In On Neonc Technologies
Hedge funds have recently bought and sold shares of the business. Bank of America Corp DE acquired a new stake in shares of Neonc Technologies in the second quarter worth about $1,017,000. HighPoint Advisor Group LLC raised its stake in shares of Neonc Technologies by 20.5% in the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company's stock valued at $9,466,000 after acquiring an additional 194,408 shares in the last quarter. BlackRock Inc. acquired a new stake in Neonc Technologies in the 2nd quarter worth approximately $815,000. Westmount Partners LLC lifted its holdings in Neonc Technologies by 355.2% in the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company's stock worth $893,000 after purchasing an additional 153,858 shares during the last quarter. Finally, Vanguard Group Inc. acquired a new stake in Neonc Technologies in the 3rd quarter worth approximately $1,279,000.
Neonc Technologies Company Profile
(
Get Free Report)
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].